August 2008
1157
weight of leaves. Although no medical use of T. gracilipes of 4 from the peak at 14 min.
The residue (2.50 g in fractions 49—58) of the 17.5—20% MeOH in
has been reported, D-mannitol has been shown to reduce the
extent of ischemic injury, and to improve myocardial, renal
and cerebral function.
CHCl eluate obtained on silica gel CC was subjected to PRCC. The residue
3
(
534 mg in fractions 213—229) was separated by DCCC (105 mg in frac-
17,18)
tions 46—65) and then by HPLC with 60% MeOH to give 10.8 mg of 5
from the peak at 22 min. The residue (634 mg in fractions 230—249) was
similarly separated by DCCC to give two fractions, 99.4 mg in fractions
Experimental
General Experimental Procedures IR spectra were obtained on a 52—61 and 261 mg in fractions 62—68. The former was finally purified by
Horiba Fourier Transform Infrared spectrophotometer FT-710. Optical rota- HPLC with 65% MeOH to give 37.7 mg of compound 6 from the peak at
1
13
tion data were measured on a JASCO P-1030 polarimeter. H- and C-NMR 8.1 min, and the latter gave 32.7 mg of 8 by HPLC purification with 65%
spectra were recorded on a JEOL JNM a-400 spectrometer at 400 and
00 MHz, respectively, with tetramethylsilane (TMS) as an internal standard.
MeOH from the peak at 10 min (flow rate: 1.3 ml/min).
The residue (2.51 g in fractions 59—65) of the 25% MeOH in CHCl elu-
1
3
HR-FAB mass spectra (negative-ion mode) and HR-ESI-TOF mass spectra ate obtained on silica gel CC was subjected to PRCC and the residue
positive-ion mode) were taken on a JEOL JMS-SX 102 mass spectrometer (220 mg in fractions 186—204) was purified by DCCC to give 10.9 mg of 2
(
and Applied Biosystems QSTAR XL System, respectively.
Highly-porous synthetic resin Diaion HP-20 (Fꢂ60 mm, Lꢂ65 cm) was
in fractions 73—90.
Tarecilioside A (4): Amorphous powder. [a] ꢀ14.5° (cꢂ2.48, pyri-
2
2
D
ꢁ1
purchased from Mitsubishi Chemical Co., Ltd. (Tokyo, Japan). Silica gel dine); IR n (film) cm : 3370, 2935, 1459, 1379, 1252, 1161, 1076, 1036;
max
1
13
column chromatography (CC) was performed on silica gel 60 [(E. Merck,
H-NMR (400 MHz, pyridine-d ) and C-NMR (100 MHz, pyridine-d ): Ta-
5
5
Darmstadt, Germany) 70—230 mesh]. Reversed-phase [octadecyl silica gel bles 1 and 2, respectively; HR-FAB-MS (negative-ion mode) m/z: 653.4239
ꢁ
(
ODS)] open CC (RPCC) was performed on Cosmosi1 75C -OPN (Nacalai [MꢁH] (Calcd for C H O : 653.4206).
18
36 61 10
2
0
Tesque, Kyoto) [Fꢂ50 mm, Lꢂ25 cm, linear gradient: MeOH–H O (1 : 9,
Tarecilioside B (5): Amorphous powder, [a] ꢀ10.8° (cꢂ0.827, pyri-
D
ꢁ1
2
1
.5 l)→(7 : 3, 1.5 l), 10 g fractions being collected]. The droplet counter-cur-
rent chromatograph (DCCC) (Tokyo Rikakikai, Tokyo, Japan) was equipped
with 500 glass columns (Fꢂ2 mm, Lꢂ40 cm), and the lower and upper lay- bles 1 and 2, respectively; HR-FAB-MS m/z: 669.4184 [MꢁH] (Calcd for
ers of a solvent mixture of CHCl –MeOH–H O–1-PrOH (9 : 12 : 8 : 2) were
C H O : 669.4155).
dine); IR n (film) cm : 3367, 2938, 1442, 1379, 1256, 1163, 1076, 1034;
max
1 13
H-NMR (400 MHz, pyridine-d ) and C-NMR (100 MHz, pyridine-d ): Ta-
5
5
ꢁ
3
2
36 61 11
2
0
used as the mobile and stationary phases, respectively. Five gram fractions
were collected and numbered according to their order of elution with the
mobile phase. HPLC was performed on an ODS (Inertsil; GL Science,
Tarecilioside C (6): Amorphous powder, [a] ꢀ13.1° (cꢂ2.51, pyri-
D
ꢁ1
dine); IR n (film) cm : 3367, 2939, 1591, 1441, 1370, 1157, 1076, 1033;
max
1
13
H-NMR (400 MHz, pyridine-d ) and C-NMR (100 MHz, pyridine-d ): Ta-
5
5
Tokyo, Japan; Fꢂ6 mm, Lꢂ5 cm, flow rate 1.6 ml/min) column. Precoated bles 1 and 2, respectively; HR-ESI-MS (positive-ion mode) m/z: 839.4739
ꢀ
silica gel 60 F2 TLC plates (E. Merck; 0.25 mm in thickness) were used for [MꢀNa] (Calcd for C H O Na: 839.4763).
54
42 72 15
2
0
identification.
Tarecilioside D (7): Amorphous powder, [a] ꢀ17.7° (cꢂ2.18, pyri-
D
ꢁ1
Plant Material Leaves of T. gracilipes OHWI were collected in Oki-
nawa, Japan, in July 2002, and a voucher specimen was deposited in the
Herbarium of Pharmaceutical Sciences, Graduate School of Biomedical Sci-
ences, Hiroshima University (02-TG-Okinawa-0705).
dine); IR n (film) cm : 3395, 2940, 1591, 1441, 1382, 1160, 1075, 1039;
max
13
1
H-NMR (400 MHz, pyridine-d ) and C-NMR (100 MHz, pyridine-d ): Ta-
5
5
bles 1 and 2, respectively; HR-ESI-MS (positive-ion mode) m/z: 825.4604
ꢀ
[MꢀNa] (Calcd for C H O Na: 825.4606).
4
1
70 15
2
0
Extraction and Isolation Air-dried leaves of Tarenna gracilipes
9.90 kg) were extracted three times with MeOH (45 lꢅ3) for one week at IR nmax (film) cm : 3395, 2930, 1650, 1458, 1381, 1161, 1075, 1038; H-
room temperature, and then the MeOH extract was concentrated to 6 l in
Tarecilioside E (8): Amorphous powder, [a] ꢀ0.6° (cꢂ0.45, pyridine);
D
ꢁ1 1
(
13
NMR (400 MHz, pyridine-d ) and C-NMR (100 MHz, pyridine-d ): Tables
5 5
vacuo. On evaporation of the MeOH extract, a colorless precipitate formed 1 and 2, respectively; HR-ESI-MS (positive-ion mode) m/z: 809.4648
ꢀ
(
1), which was collected by suction (415 g). A portion of the precipitates was [MꢀNa] (Calcd for C H O Na: 809.4657).
41 70 14
2
0
recrystallized from EtOH to give colorless prisms. The extract was washed
Tarecilioside F (9): Amorphous powder, [a] ꢀ7.1° (cꢂ0.693, pyridine);
D
ꢁ1 1
with n-hexane (6 l) and then the methanolic layer was concentrated to a vis- IR nmax (film) cm : 3368, 2937, 1705, 1461, 1381, 1163, 1076, 1033; H-
cous gum (n-hexane-soluble fraction: 58.8 g). The gummy residue was sus- NMR (400 MHz, pyridine-d ) and C-NMR (100 MHz, pyridine-d ): Tables
1
3
5
5
pended in H O (6 l) and then extracted with EtOAc (6 l) to give 172 g of an 1 and 2, respectively; HR-FAB-MS (negative-ion mode) m/z: 813.4643
2
ꢁ
EtOAc-soluble fraction. The aqueous layer was extracted with 1-BuOH (6 l) [MꢁH] (Calcd for C H O : 813.4636).
4
2
69 15
2
0
to give 149 g of a 1-BuOH-soluble fraction. The remaining water-layer was
concentrated to furnish 248 g of a water-soluble fraction.
Tarecilioside G (10): Amorphous powder. [a] ꢀ15.6° (cꢂ0.43, pyri-
D
ꢁ1
dine); IR n (film) cm : 3376, 2935, 1702, 1458, 1370, 1165, 1075, 1034;
max
1
13
The 1-BuOH-soluble extract (149 g) was applied to highly porous syn-
thetic resin (Diaion HP-20) CC (Fꢂ60 mm, Lꢂ65 cm), using a stepwise-
H-NMR (400 MHz, pyridine-d ) and C-NMR (100 MHz, pyridine-d ): Ta-
5
5
bles 1 and 2, respectively; HR-ESI-MS (positive-ion mode) m/z: 837.4613
ꢀ
gradient of MeOH–H O [(1 : 4, 6 l), (2 : 3, 6 l), (3 : 2, 6 l), (4 : 1, 6 l), and
[MꢀNa] (Calcd for C H O Na: 837.4606).
2
42 70 15
MeOH (6 l)], 500 ml factions being collected. The residue eluted with the
Known Compounds Isolated D-Mannitol (1): Colorless prisms, mp
2
0
20% MeOH (50.7 g in fractions 2—4) eluate obtained on HP-20 CC was
160—160 °C (EtOH), [a] ꢀ19.6° (cꢂ10.0, 2 ml of H O containing
D 2
2)
subjected to silica gel (1.0 kg) CC using CHCl (6 l), CHCl –MeOH [(99 : 1,
256 mg of Borax).
(R)-Linalool 6-O-a-L-Arabinopyranosyl-b-D-glucopyranoside (2): Amor-
3
3
6
l), (97 : 3, 6 l), (19 : 1, 6 l), (37 : 3, 6 l), (9 : 1, 6 l), (7 : 17, 6 l), (17 : 3, 6 l),
2
0
3)
(
33 : 7, 6 l), (4 : 4, 6 l), (7 : 3, 6 l)], and CHCl –MeOH–H O (35 : 15 : 2, 3 l),
phous powder, [a]D ꢁ24.0° (cꢂ1.00, MeOH).
26
3
2
4)
1
1
l fractions being collected. The residue (2.25 g in fractions 39—49) of the
Mussaenoside (3): Amorphous powder, [a] ꢁ77.8° (cꢂ1.26, MeOH).
D
Acid Hydrolysis of Tarecilioside A (4) A solution of tarecilioside A (4)
2.5—15% MeOH in CHCl eluate was subjected to PRCC and then the
3
residue (79.4 mg in fractions 105—114) was purified by HPLC with 40%
(10.0 mg) in 2 ml of 1 N HCl–dioxane (1 : 1) was heated at 100 °C for 1 h
MeOH to afford 18.9 mg of compound 3 from the peak at 28 min (flow rate: under a N atmosphere. After cooling, the reaction mixture was neutralized
2
0.4 ml/min). The residue (228 mg in fractions 66—73) of the 25% MeOH in
by the addition of Amberlite IRA-96SB, and then chromatographed on silica
CHCl eluate afforded 20.0 mg of 1.
gel (7.0 g), with elution with a linear gradient mixture of CHCl –MeOH
3
3
The residue eluted with the 60—80% MeOH (29.6 g in fractions 14—19)
eluate obtained on HP-20 CC was subjected to silica gel (500 g) CC using
CHCl (3 l), CHCl –MeOH [(99 : 1, 3 l), (97 : 3, 3 l), (19 : 1, 3 l), (37 : 3, 3 l),
(20 : 1, 100 ml) to (1 : 1, 100 ml), 5 ml fractions being collected. An aglycone
(4a) and D-glucose were recovered in fractions 12—18 (2.62 mg, 38%) and
19—23 (1.74 mg, 63 %), respectively. Aglycone (4a), amorphous powder,
3
3
2
0
1
(9 : 1, 3 l), (7 : 1, 3 l), (17 : 3, 3 l), (33 : 7, 3 l), (4 : 1, 3 l), (3 : 1, 3 l), (7 : 3, 3 l)],
[a] ꢀ23.8° (cꢂ0.17, pyridine); H-NMR (400 MHz, pyridine-d ) d: 0.29
D
5
and CHCl –MeOH–H O (35 : 15 : 2, 3 l), fractions of 500 ml being collected.
(1H, d, Jꢂ4 Hz, H-19a), 0.76 (1H, d, Jꢂ4 Hz, H-19b), 1.05 (3H, s, H -28),
3
2
3
The residue (2.00 g in fractions 42—48) of the 15% MeOH in CHCl eluate
1.10 (3H, s, H -30), 1.10 (3H, d, Jꢂ6 Hz, H -21), 1.17 (3H, s, H -29), 1.44
3
3
3
3
was subjected to PRCC. The residue (30.8 mg in fractions 211—225) was
separated by DCCC to afford 9.1 mg of 9 in fractions 60—78 and 6.8 mg of
compound 7 in fractions 79—88. The residue (35.9 mg in fractions 96—
(3H, s, H -26), 1.45 (3H, s, H -18), 1.48 (3H, s, H -27), 2.00 (1H, d,
3
3
3
Jꢂ10 Hz, H-8), 2.29 (1H, dd, Jꢂ13, 4 Hz, H-15a), 2.71 (1H, dd, Jꢂ13,
8 Hz, H-15b), 3.50 (1H, dd, Jꢂ11, 4 Hz, H-3), 3.74 (1H, dd, Jꢂ10, 2 Hz, H-
1
3
1
21) of the eluate obtained on DCCC was purified by HPLC with 57%
MeOH to afford 7.20 mg of 10 from the peak at 12 min (flow rate: d: 14.7 (C-28), 18.8 (C-18), 18.9 (C-21), 20.0 (C-30), 20.3 (C-9), 25.7 (C-
.9 ml/min). The residue (60.7 mg in fractions 122—163) of the eluate ob-
29), 26.0 (C-27), 26.2 (C-26), 26.9 (C-11), 27.2 (C-10), 28.9 (C-19), 29.5
tained on DCCC was purified by HPLC with 65% MeOH to afford 33.2 mg (C-23), 30.0 (C-1), 31.0 (C-2), 31.5 (C-20), 32.2 (C-6), 33.2 (C-12), 35.0
24), 4.71 (1H, ddd, Jꢂ8, 8, 5 Hz, H-16); C-NMR (100 MHz, pyridine-d5)
0